Chmielewska I, Dudzinska M, Szczyrek M, Swirska J, et al. Do endocrine adverse events predict longer progression-free survival among patients with non-small-cell lung cancer receiving nivolumab? PLoS One 2021;16:e0257484.
PMID: 34587185